Safety of Selective Serotonin Reuptake Inhibitors in Pregnancy

ISSN： 1172-7047

Source： CNS Drugs, Vol.23, Iss.6, 2009-05, pp. : 493-509

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Selective Serotonin Reuptake Inhibitors in Pregnancy

Current Medicinal Chemistry, Vol. 19, Iss. 27, 2012-09 ,pp. : 4554-4561

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment with Selective Serotonin Reuptake Inhibitors in the Third Trimester of Pregnancy: Effects on the Infant

By Nordeng Hedvig Spigset Olav

Drug Safety, Vol. 28, Iss. 7, 2005-01 ,pp. : 565-581

Adis International

Access to resources Recommend Favorite

The safety of serotonin–noradrenaline reuptake inhibitors (SNRIs) in pregnancy and breastfeeding: a comprehensive review

Human Psychopharmacology: Clinical And Experimental (Electronic), Vol. 30, Iss. 3, 2015-05 ,pp. : 143-151

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment of premenstrual dysphoria with selective serotonin re-uptake inhibitors: focus on safety

By Macdougall Mary Steiner Meir

Expert Opinion on Drug Safety, Vol. 2, Iss. 2, 2003-03 ,pp. : 161-166

Informa Healthcare

Access to resources Recommend Favorite

Use of Selective Serotonin Reuptake Inhibitors in Children and Adolescents

By Ian C.K. Wong

Drug Safety, Vol. 27, Iss. 13, 2004-01 ,pp. : 991-1000

Adis International

Access to resources Recommend Favorite